Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/11/2014US20140255380 Methods of administering 3, 4-diaminopyridine
09/11/2014US20140255372 Co-enzyme q10 formulations and methods of use
09/11/2014US20140255371 Physical Optimization Beverage
09/11/2014US20140255370 Dietary Supplement Composition
09/11/2014US20140255367 Sweetening and Healthy Compositions and Methods Associated Therewith
09/11/2014US20140255363 Targeting the tumor microenvironment using manipulated nkt cells
09/11/2014US20140255360 Modified caspase polypeptides and uses thereof
09/11/2014US20140255358 Generation of immunosuppressive myeloid cells using pge2
09/11/2014US20140255348 Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
09/11/2014US20140255344 Antiviral Compounds
09/11/2014US20140255342 Thiophene derivatives
09/11/2014US20140255341 Tumor Selective Chemokine Modulation
09/11/2014US20140255340 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
09/11/2014US20140255339 Compounds and pharmaceutical compositions for the treatment of viral infections
09/11/2014US20140255336 Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use
09/11/2014US20140255335 Inherently radiopaque polymeric products for embolotherapy
09/11/2014US20140255334 Bone graft materials containing calcium phosphate and povidone-iodine
09/11/2014US20140255332 Ophthalmic formulations
09/11/2014US20140255330 Mixed Sugar Compositions
09/11/2014US20140255322 Siloxane polymer and actives
09/11/2014US20140255318 Nitric oxide releasing bath compositions and methods of using the same
09/11/2014US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
09/11/2014US20140255311 Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide
09/11/2014DE102013204088A1 Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen Active compound combinations of Alkylamidothiazolen and one or more cosmetically or dermatologically relevant fragrances
09/11/2014DE102013204081A1 Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln Active compound combinations of Alkylamidothiazolen and one or more cosmetically or dermatologically acceptable preservatives
09/11/2014DE102013204070A1 Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung Use of cosmetically or dermatologically acceptable substituted Michael acceptors for the prevention, reduction or prevention of the tyrosinase activity of the human skin and / or brightening
09/11/2014DE102013003756A1 Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen Piroxicam for the prophylactic and therapeutic treatment of CMV infections
09/11/2014DE102013003107A1 Naphthofurandione mit einer 1-Bromalkylgruppe oder einer 1-Hydroxyalkylgruppe in 2-Position und einer Alkylgruppe in 3-Position zum Furanring-Sauerstoff und Verfahren zu deren Herstellung Naphthofurandione with a 1-bromoalkyl group or a 1-hydroxyalkyl group at the 2-position and an alkyl group in the 3-position on the furan ring-oxygen and methods for their preparation
09/10/2014EP2775001A1 MicroRNA signatures in human ovarian cancer
09/10/2014EP2774990A1 Loop-shRNAs
09/10/2014EP2774989A1 Double-stranded nucleic acid molecule for gene expression control
09/10/2014EP2774953A1 Gelatable compositions
09/10/2014EP2774932A1 Novel compound contained in manuka honey and use of same
09/10/2014EP2774928A1 Polycyclic pyridone derivative having integrase-inhibiting activity
09/10/2014EP2774927A1 Inhibitors of HCV NS5A
09/10/2014EP2774926A1 Morphinan derivative
09/10/2014EP2774925A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters
09/10/2014EP2774920A1 Crystalline forms of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt and their medical use
09/10/2014EP2774919A1 Novel sulfonamide TRPA1 receptor antagonists
09/10/2014EP2774917A1 Pharmaceutical composition for treating diabetes
09/10/2014EP2774914A1 N-benzylaniline derivative and uses thereof
09/10/2014EP2774912A1 Cationic lipid
09/10/2014EP2774910A1 Enantiomers of 2-hydroxy derivatives of fatty acids
09/10/2014EP2774623A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
09/10/2014EP2774622A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
09/10/2014EP2774618A2 Pharmaceutical composition based on epigallocatechin gallate-containing nano-micelles and use thereof to treat atopic dermatitis, crohn's disease, adenomyosis and hyperplastic prostate disorders
09/10/2014EP2774614A1 Use of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/media for lactose-free oral contraception
09/10/2014EP2774613A1 Drugs for inhibiting p38 and uses thereof
09/10/2014EP2774612A1 4-Methylpyrazole formulations
09/10/2014EP2774611A1 Magnetic composition, and method for producing same
09/10/2014EP2774610A1 Photosensitizer for use as Virus-inactivating medicaments
09/10/2014EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
09/10/2014EP2774608A1 Drug loaded polymeric nanoparticles and methods of making and using same
09/10/2014EP2774606A1 Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
09/10/2014EP2773760A1 Double-stranded RNA for immunostimulation
09/10/2014EP2773759A1 Aptamers
09/10/2014EP2773758A2 Methods and compositions for neuroprotection
09/10/2014EP2773675A1 Quick-acting insulin formulation including an oligosaccharide
09/10/2014EP2773645A1 Imidazopyridazine compounds
09/10/2014EP2773644A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase
09/10/2014EP2773643A1 Pak inhibitors for the treatment of fragile x syndrome
09/10/2014EP2773642A1 Pak inhibitors for the treatment of cell proliferative disorders
09/10/2014EP2773641A1 Biaryl ether sulfonamides and their use as therapeutic agents
09/10/2014EP2773640A1 Bicyclic piperazine compounds
09/10/2014EP2773639A1 Alkylated piperazine compounds as inhibitors of btk activity
09/10/2014EP2773638A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity
09/10/2014EP2773637A1 Benzenesulfonamide compounds and their use as therapeutic agents
09/10/2014EP2773636A1 Optically active fluconazole analogues containing thiophenes as antifungal agents
09/10/2014EP2773635A1 Compounds and compositions for modulating egfr activity
09/10/2014EP2773634A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl]pyrrolidine - 1 - carbonlymethyl} amine
09/10/2014EP2773633A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
09/10/2014EP2773632A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
09/10/2014EP2773624A1 Novel process for the preparation of acylguanidines and acylthioureas
09/10/2014EP2773623A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
09/10/2014EP2773620A1 Ivabradine hydrochloride form iv
09/10/2014EP2773619A1 New aryl-quinoline derivatives
09/10/2014EP2773617A1 Pesticidal compounds
09/10/2014EP2773616A1 Pesticidal compounds
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/10/2014EP2773609A2 Nicotinic receptor non-competitive modulators
09/10/2014EP2773426A1 Combinational liposome compositions for cancer therapy
09/10/2014EP2773382A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration
09/10/2014EP2773379A2 Subcutaneous delivery of polymer conjugates of therapeutic agents
09/10/2014EP2773369A1 Compositions and methods for preventing and treating oral diseases
09/10/2014EP2773363A1 Nutritional supplement for weight management
09/10/2014EP2773361A1 Method for improving executive function
09/10/2014EP2773360A2 Administration of nedd8-activating enzyme inhibitor and hypomethylating agent
09/10/2014EP2773359A2 Crystalline and non-crystalline forms of sglt2 inhibitors
09/10/2014EP2773358A1 Compositions and methods for hemostasis
09/10/2014EP2773357A1 Methods and compositions for modulating gastrointestinal bacteria to promote health
09/10/2014EP2773356A1 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17 -carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
09/10/2014EP2773355A1 Methods, formulations, and kits for rapidly repleting folate levels in women
09/10/2014EP2773354A1 Oral immediate release formulations for substituted quinazolinones
09/10/2014EP2773353A1 N-(3-{[(3-{[2-chloro-5-(methoxy)phenyl]amino}quinoxalin-2-yl)amino]sulfonyl}phenyl)-2-methylalaninamide as phosphatidylinositol 3-kinase inhibitor for the treatment of lymphoproliferative malignancies
09/10/2014EP2773352A2 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists
09/10/2014EP2773351A2 Inhibitors of the renal outer medullary potassium channel
09/10/2014EP2773350A1 A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent
09/10/2014EP2773349A1 Use of (n- [2, 4 -bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl]- 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide) for treating cftr mediated diseases
09/10/2014EP2773348A1 Pharmaceutical composition of omeprazole
09/10/2014EP2773347A1 Dabigatran-amidoxime acid esters as prodrugs and use thereof as pharmaceuticals
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 7860